⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
LICI - Fundamental Analysis: Financial Health & Valuation
Last Updated Time : 20 Dec 25, 11:15 pm
Back to Fundamental ListFundamental Rating: 4.3
| Stock Code | LICI | Market Cap | 5,39,206 Cr. | Current Price | 852 ₹ | High / Low | 980 ₹ |
| Stock P/E | 10.5 | Book Value | 223 ₹ | Dividend Yield | 1.42 % | ROCE | 53.4 % |
| ROE | 46.0 % | Face Value | 10.0 ₹ | DMA 50 | 884 ₹ | DMA 200 | 889 ₹ |
| Chg in FII Hold | 0.02 % | Chg in DII Hold | -0.02 % | PAT Qtr | 10,053 Cr. | PAT Prev Qtr | 10,987 Cr. |
| RSI | 33.9 | MACD | -13.0 | Volume | 43,20,163 | Avg Vol 1Wk | 18,20,029 |
| Low price | 715 ₹ | High price | 980 ₹ | PEG Ratio | 0.08 | Debt to equity | 0.00 |
| 52w Index | 51.8 % | Qtr Profit Var | 31.9 % | EPS | 80.8 ₹ | Industry PE | 84.3 |
📊 Core Financials
- Quarterly PAT at ₹10,053 Cr. vs ₹10,987 Cr. shows slight decline, but overall profit variation is +31.9% YoY.
- ROCE at 53.4% and ROE at 46.0% indicate exceptional efficiency and profitability.
- Debt-to-equity ratio at 0.00 highlights a debt-free balance sheet, ensuring strong financial health.
- EPS at ₹80.8 reflects robust earnings power.
💹 Valuation Indicators
- P/E Ratio: 10.5 (significantly below industry PE of 84.3, suggesting undervaluation).
- P/B Ratio: ~3.8 (CMP ₹852 / Book Value ₹223).
- PEG Ratio: 0.08 (extremely attractive, highlighting undervaluation relative to growth).
- Intrinsic Value: CMP appears undervalued, offering strong margin of safety.
🏢 Business Model & Competitive Advantage
- LIC is India’s largest life insurer with dominant market share and unparalleled brand trust.
- Competitive advantage lies in its extensive distribution network, government backing, and strong customer base.
- Focus on insurance penetration, digital adoption, and diversified product offerings supports long-term sustainability.
📈 Entry Zone & Long-Term Guidance
- Entry Zone: Attractive near ₹800–₹850 (close to DMA 200 at ₹889 and 52-week low ₹715).
- Long-Term Holding: Highly suitable for investors seeking undervalued insurance exposure with strong fundamentals.
✅ Positive
- Exceptional ROCE (53.4%) and ROE (46.0%) highlight efficiency and profitability.
- P/E at 10.5 is far below industry average, showing undervaluation.
- Debt-free balance sheet ensures financial stability.
- EPS of ₹80.8 demonstrates strong earnings power.
⚠️ Limitation
- Quarterly PAT declined slightly from ₹10,987 Cr. to ₹10,053 Cr.
- Dividend yield at 1.42% is modest compared to peers.
- Stock trading below DMA 50 & DMA 200, reflecting weak technical momentum.
📉 Company Negative News
- DII holdings reduced (-0.02%), showing cautious domestic sentiment.
- Short-term profit decline may affect near-term investor confidence.
📈 Company Positive News
- FII holdings increased slightly (+0.02%), showing foreign investor confidence.
- Strong brand trust and government backing continue to support long-term growth.
🏭 Industry
- Insurance industry benefits from rising penetration, financial awareness, and regulatory support in India.
- Industry PE at 84.3, showing LIC trades at a deep discount to peers.
🔎 Conclusion
LIC demonstrates exceptional fundamentals with high ROE/ROCE, debt-free balance sheet, and undervaluation compared to industry peers. Despite modest dividend yield and slight quarterly profit decline, the company’s dominant market position and strong brand trust make it a compelling long-term investment. Entry is advisable near ₹800–₹850 for better risk-reward. Long-term investors may benefit significantly from insurance sector growth and LIC’s unmatched scale.
Back to Fundamental ListNIFTY 50 - Today Top Fundamental Picks Stock Picks
NEXT 50 - Today Top Fundamental Picks Stock Picks
MIDCAP - Today Top Fundamental Picks Stock Picks
SMALLCAP - Today Top Fundamental Picks Stock Picks